Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant chemotherapy in stage II colorectal cancerResearch in context
Summary: Background: Adjuvant chemotherapy provides a limited survival benefit (<5%) for patients with stage II colorectal cancer (CRC) and is suggested for high-risk patients. Given the heterogeneity of stage II CRC, we aimed to develop a clinically explainable artificial intelligence (AI)-powe...
Saved in:
| Main Authors: | Chenyi Xie, Ziyu Ning, Ting Guo, Lisha Yao, Xiaobo Chen, Wanghong Huang, Suyun Li, Jiahui Chen, Ke Zhao, Xiuwu Bian, Zhenhui Li, Yanqi Huang, Changhong Liang, Qingling Zhang, Zaiyi Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | EBioMedicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396425002336 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MRI-based multimodal AI model enables prediction of recurrence risk and adjuvant therapy in breast cancer
by: Yunfang Yu, et al.
Published: (2025-06-01) -
3D spectral CT-based fusion model predicts prognosis and postoperative adjuvant chemotherapy benefit in locally advanced rectal cancer
by: Shuxuan Fan, et al.
Published: (2025-08-01) -
GWAS meta-analysis identifies five susceptibility loci for endometrial cancerResearch in context
by: Dhanya Ramachandran, et al.
Published: (2025-08-01) -
Multimodal Machine Learning‐Based Marker Enables Early Detection and Prognosis Prediction for Hyperuricemia
by: Lin Zeng, et al.
Published: (2024-09-01) -
Survival outcomes in trial defined high-risk hormone receptor-positive/human epidermal growth factor receptor II-negative early breast cancer: impact of adjuvant chemotherapy
by: Ta-Chung Chao, et al.
Published: (2025-05-01)